A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Clinical trial NCT00975767 · TERMINATED
Trial details
- NCT number
- NCT00975767
- Sponsor
- Mirati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2013-07-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.